MedTrace Logo

Macronutrient Distribution and Plasma Metabolites to Model Meals Composition

NCT04928872 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2022-02-21

No results posted yet for this study

Summary

Continuous glucose monitors (CGMs) measure plasma glucose concentration continually and thus they are a key tool in the management of diabetes, including type 2 diabetes (T2D). A key factor in diabetes management is a reduction of dietary carbohydrates (CHO) and/or exchanging high glycemic index (GI) CHO with low GI CHO. However, the protein and fat content of the meal can have a significant impact on the glucose readings obtained from a CGM as there is no enough data available on their sensitivity during meals.

Conditions

  • Glucose Metabolism

Interventions

COMBINATION_PRODUCT

Predefined meal

Nine predefined meals are administered in a randomized fashion, one meal per one study day, 2-3 study days per week. Meals have a form of drinks with different compositions of protein, carbohydrates and fat in relation to the US diet

Sponsors & Collaborators

Principal Investigators

  • Nicolaas EP Deutz, MD, PhD · Texas A&M University

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2020-01-14
Completion
2020-01-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04928872 on ClinicalTrials.gov